Bruce Hollis to Middle Aged
This is a "connection" page, showing publications Bruce Hollis has written about Middle Aged.
Connection Strength
0.655
-
Maternal Versus Infant Vitamin D Supplementation During Lactation: A Randomized Controlled Trial. Pediatrics. 2015 Oct; 136(4):625-34.
Score: 0.036
-
Vitamin d and the risk of uterine fibroids. Epidemiology. 2013 May; 24(3):447-53.
Score: 0.031
-
Vitamin D status and impact of vitamin D3 and/or calcium supplementation in a randomized pilot study in the Southeastern United States. J Am Coll Nutr. 2009 Dec; 28(6):678-86.
Score: 0.024
-
The effect of daily intake of vitamin D-fortified yogurt drink, with and without added calcium, on serum adiponectin and sirtuins 1 and 6 in adult subjects with type 2 diabetes. Nutr Diabetes. 2021 07 30; 11(1):26.
Score: 0.014
-
Daily intake of yogurt drink fortified either with vitamin D alone or in combination with added calcium causes a thyroid-independent increase of resting metabolic rate in adults with type 2 diabetes: a randomized, double-blind, clinical trial. Appl Physiol Nutr Metab. 2021 Nov; 46(11):1363-1369.
Score: 0.013
-
Comparison of commercially available (125)I-based RIA methods for the determination of circulating 25-hydroxyvitamin D. Clin Chem. 2000 Oct; 46(10):1657-61.
Score: 0.013
-
Prediagnostic Circulating Concentrations of Vitamin D Binding Protein and Survival among Patients with Colorectal Cancer. Cancer Epidemiol Biomarkers Prev. 2020 11; 29(11):2323-2331.
Score: 0.013
-
Vitamin D Synthesis Following a Single Bout of Sun Exposure in Older and Younger Men and Women. Nutrients. 2020 Jul 27; 12(8).
Score: 0.013
-
Resolution of vitamin D insufficiency in osteopenic patients results in rapid recovery of bone mineral density. J Clin Endocrinol Metab. 1999 Aug; 84(8):2729-30.
Score: 0.012
-
Helicobacter pylori treatment and antibiotic susceptibility: results of a five-year audit. Aust N Z J Med. 1999 Aug; 29(4):512-6.
Score: 0.012
-
Serum Levels of 25-Hydroxyvitamin D at Diagnosis Are Not Associated with Overall Survival in Esophageal Adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 2019 08; 28(8):1379-1387.
Score: 0.012
-
Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial. JAMA. 2019 04 09; 321(14):1370-1379.
Score: 0.012
-
Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging. 1999; 3(1):5-7.
Score: 0.011
-
Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations =60 vs <20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort. PLoS One. 2018; 13(6):e0199265.
Score: 0.011
-
Vitamin D supplementation and body fat mass: a systematic review and meta-analysis. Eur J Clin Nutr. 2018 10; 72(10):1345-1357.
Score: 0.011
-
Systems analysis of the prostate transcriptome in African-American men compared with European-American men. Pharmacogenomics. 2016 07; 17(10):1129-1143.
Score: 0.010
-
Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls. Mult Scler. 2016 05; 22(6):753-60.
Score: 0.009
-
Effects of Vitamin D Supplementation on C-peptide and 25-hydroxyvitamin D Concentrations at 3 and 6 Months. Sci Rep. 2015 Jun 22; 5:10411.
Score: 0.009
-
Null association between vitamin D and PSA levels among black men in a vitamin D supplementation trial. Cancer Epidemiol Biomarkers Prev. 2014 Sep; 23(9):1944-7.
Score: 0.008
-
Risk of hypercalcemia in blacks taking hydrochlorothiazide and vitamin D. Am J Med. 2014 Aug; 127(8):772-8.
Score: 0.008
-
Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial. Am J Clin Nutr. 2014 Mar; 99(3):587-98.
Score: 0.008
-
Impact of vitamin D supplementation on inflammatory markers in African Americans: results of a four-arm, randomized, placebo-controlled trial. Cancer Prev Res (Phila). 2014 Feb; 7(2):218-25.
Score: 0.008
-
Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol. 2014 Mar; 25(3):564-72.
Score: 0.008
-
Relationship between vitamin D status and incidence of vascular events in the Veterans Affairs Diabetes Trial. Atherosclerosis. 2013 Jun; 228(2):502-7.
Score: 0.008
-
Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors. Cancer Causes Control. 2013 Apr; 24(4):759-67.
Score: 0.008
-
Vitamin D3 supplementation (4000 IU/d for 1 y) eliminates differences in circulating 25-hydroxyvitamin D between African American and white men. Am J Clin Nutr. 2012 Aug; 96(2):332-6.
Score: 0.007
-
Vitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary study. J Investig Med. 2012 Jun; 60(5):801-7.
Score: 0.007
-
Characterization of vitamin D receptor (VDR) in lung adenocarcinoma. Lung Cancer. 2012 Aug; 77(2):265-71.
Score: 0.007
-
Vitamin D3 supplementation at 4000 international units per day for one year results in a decrease of positive cores at repeat biopsy in subjects with low-risk prostate cancer under active surveillance. J Clin Endocrinol Metab. 2012 Jul; 97(7):2315-24.
Score: 0.007
-
Vitamin D-related genetic variation, plasma vitamin D, and risk of lethal prostate cancer: a prospective nested case-control study. J Natl Cancer Inst. 2012 May 02; 104(9):690-9.
Score: 0.007
-
Interactions between plasma levels of 25-hydroxyvitamin D, insulin-like growth factor (IGF)-1 and C-peptide with risk of colorectal cancer. PLoS One. 2011; 6(12):e28520.
Score: 0.007
-
Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D Levels among African Americans. PLoS One. 2011; 6(12):e28623.
Score: 0.007
-
Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum Genomics. 2011 Oct; 5(6):538-68.
Score: 0.007
-
Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial. Br J Nutr. 2011 Aug; 106(3):339-44.
Score: 0.007
-
Plasma 25-hydroxyvitamin D and risk of breast cancer in the Nurses' Health Study II. Breast Cancer Res. 2011 May 11; 13(3):R50.
Score: 0.007
-
Cord blood vitamin D status impacts innate immune responses. J Clin Endocrinol Metab. 2011 Jun; 96(6):1835-43.
Score: 0.007
-
Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One. 2011 Apr 06; 6(4):e18625.
Score: 0.007
-
Circulating levels of vitamin D and colon and rectal cancer: the Physicians' Health Study and a meta-analysis of prospective studies. Cancer Prev Res (Phila). 2011 May; 4(5):735-43.
Score: 0.007
-
Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741. J Clin Oncol. 2011 Apr 20; 29(12):1599-606.
Score: 0.007
-
Cutaneous formation of vitamin D in psoriasis. Arch Dermatol. 1990 Aug; 126(8):1107-8.
Score: 0.006
-
The relationship of 1,25-dihydroxyvitamin D and radial bone mass. Bone Miner. 1990 Aug; 10(2):139-48.
Score: 0.006
-
Blood vitamin d levels in relation to genetic estimation of African ancestry. Cancer Epidemiol Biomarkers Prev. 2010 Sep; 19(9):2325-31.
Score: 0.006
-
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev. 2010 Sep; 9(11):709-15.
Score: 0.006
-
Serum vitamin D and breast density in breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2010 Feb; 19(2):412-7.
Score: 0.006
-
Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose. J Clin Endocrinol Metab. 2010 Mar; 95(3):1279-87.
Score: 0.006
-
Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer. Br J Cancer. 2009 Sep 15; 101(6):916-23.
Score: 0.006
-
Vitamin D deficiency and insufficiency among patients with prostate cancer. BJU Int. 2009 Oct; 104(7):909-14.
Score: 0.006
-
A prospective investigation of serum 25-hydroxyvitamin D and risk of lymphoid cancers. Int J Cancer. 2009 Feb 15; 124(4):979-86.
Score: 0.006
-
Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res. 2009 Feb 15; 69(4):1439-47.
Score: 0.006
-
Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin Oncol. 2008 Dec 01; 26(34):5596-602.
Score: 0.006
-
Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr. 2008 Jul; 88(1):133-9.
Score: 0.006
-
Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol. 2008 Jun 20; 26(18):2984-91.
Score: 0.005
-
25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med. 2008 Jun 09; 168(11):1174-80.
Score: 0.005
-
Serum vitamin D concentration and prostate cancer risk: a nested case-control study. J Natl Cancer Inst. 2008 Jun 04; 100(11):796-804.
Score: 0.005
-
Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2008 Apr; 17(4):889-94.
Score: 0.005
-
Vitamin D insufficiency in southern Arizona. Am J Clin Nutr. 2008 Mar; 87(3):608-13.
Score: 0.005
-
Lack of effect of exogenous calcitriol on the cutaneous production of vitamin D3. J Clin Endocrinol Metab. 1988 Feb; 66(2):451-3.
Score: 0.005
-
Vitamin D insufficiency among African-Americans in the southeastern United States: implications for cancer disparities (United States). Cancer Causes Control. 2008 Jun; 19(5):527-35.
Score: 0.005
-
Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UVB dose and skin color. J Am Acad Dermatol. 2007 Oct; 57(4):588-93.
Score: 0.005
-
A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer. J Natl Cancer Inst. 2007 Jul 18; 99(14):1120-9.
Score: 0.005
-
Vitamin D status of patients admitted to a hospital rehabilitation unit: relationship to function and progress. Am J Phys Med Rehabil. 2007 Jun; 86(6):435-45.
Score: 0.005
-
Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab. 2007 Jun; 92(6):2130-5.
Score: 0.005
-
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer. Cancer Epidemiol Biomarkers Prev. 2007 Apr; 16(4):783-8.
Score: 0.005
-
Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin Oncol. 2007 Feb 10; 25(5):479-85.
Score: 0.005
-
Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 Dec 20; 296(23):2832-8.
Score: 0.005
-
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst. 2006 Apr 05; 98(7):451-9.
Score: 0.005
-
Safety and tolerability of subcutaneous PTHrP(1-36) in healthy human volunteers: a dose escalation study. Osteoporos Int. 2006 Feb; 17(2):225-30.
Score: 0.005
-
Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2005 Aug; 14(8):1991-7.
Score: 0.004
-
Bioavailability of vitamin D from fortified process cheese and effects on vitamin D status in the elderly. J Dairy Sci. 2005 Jul; 88(7):2295-301.
Score: 0.004
-
Vitamin d deficiency and seasonal variation in an adult South Florida population. J Clin Endocrinol Metab. 2005 Mar; 90(3):1557-62.
Score: 0.004
-
Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004 Nov; 89(11):5387-91.
Score: 0.004
-
Plasma vitamin D metabolites and risk of colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 2004 Sep; 13(9):1502-8.
Score: 0.004
-
Plasma levels of 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D and the risk of prostate cancer. J Steroid Biochem Mol Biol. 2004 May; 89-90(1-5):533-7.
Score: 0.004
-
Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev. 2004 Apr; 13(4):546-52.
Score: 0.004
-
Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and subsequent risk of prostate cancer. Cancer Causes Control. 2004 Apr; 15(3):255-65.
Score: 0.004
-
Pharmacokinetics and safety of ILX23-7553, a non-calcemic-vitamin D3 analogue, in a phase I study of patients with advanced malignancies. Invest New Drugs. 2003 Nov; 21(4):445-52.
Score: 0.004
-
Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988-1994. Am J Clin Nutr. 2002 Jul; 76(1):187-92.
Score: 0.004
-
Diminished and erratic absorption of ergocalciferol in adult cystic fibrosis patients. Am J Clin Nutr. 2001 Mar; 73(3):602-6.
Score: 0.003
-
Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers Prev. 2000 Oct; 9(10):1059-65.
Score: 0.003
-
Genetic markers, bone mineral density, and serum osteocalcin levels. J Bone Miner Res. 1999 Aug; 14(8):1411-9.
Score: 0.003
-
The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre- and perimenopausal women. Arthritis Rheum. 1999 Mar; 42(3):483-9.
Score: 0.003
-
Vitamin D receptor genotype and the risk of bone fractures in women. Epidemiology. 1998 Sep; 9(5):535-9.
Score: 0.003
-
Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control. 1997 Jul; 8(4):615-25.
Score: 0.003
-
An audit of low dose triple therapy for eradication of Helicobacter pylori. N Z Med J. 1996 Aug 09; 109(1027):290-2.
Score: 0.002
-
Circulating vitamin D metabolites in relation to subsequent development of prostate cancer. Cancer Epidemiol Biomarkers Prev. 1996 Feb; 5(2):121-6.
Score: 0.002
-
Prostate cancer and prediagnostic levels of serum vitamin D metabolites (Maryland, United States) Cancer Causes Control. 1995 May; 6(3):235-9.
Score: 0.002
-
Diclofenac sodium inhibits bone resorption in postmenopausal women. Am J Med. 1994 Apr; 96(4):349-53.
Score: 0.002
-
Human plasma transport of vitamin D after its endogenous synthesis. J Clin Invest. 1993 Jun; 91(6):2552-5.
Score: 0.002
-
Biochemical parameters associated with low bone density in healthy men and women. J Bone Miner Res. 1992 Oct; 7(10):1123-30.
Score: 0.002
-
Radial bone mineral density in pre- and perimenopausal women: a prospective study of rates and risk factors for loss. J Bone Miner Res. 1992 Jun; 7(6):647-57.
Score: 0.002
-
Ten weeks of intermittent hypocalcemic stimulation does not produce functional parathyroid hyperplasia. Am J Med Sci. 1991 Sep; 302(3):138-41.
Score: 0.002
-
Cutaneous vitamin D3 formation in progressive systemic sclerosis. J Rheumatol. 1991 Aug; 18(8):1196-8.
Score: 0.002
-
Lithium treatment increases intact and midregion parathyroid hormone and parathyroid volume. J Clin Endocrinol Metab. 1989 Mar; 68(3):654-60.
Score: 0.001
-
Relationship between 1,25-dihydroxyvitamin D and blood pressure in a geographically defined population. Am J Clin Nutr. 1988 Oct; 48(4):1053-6.
Score: 0.001
-
Alteration in osteoblast activity and nutritional vitamin-D deficiency in non-hypercalcemic malignancy. Calcif Tissue Int. 1988 Jan; 42(1):18-22.
Score: 0.001
-
Parameters related to 25-OH-D levels in a population-based study of women. Am J Clin Nutr. 1986 Apr; 43(4):621-8.
Score: 0.001
-
Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism. J Clin Invest. 1980 Oct; 66(4):782-91.
Score: 0.001